Table 4.
Adverse events | BIS initiation at week 2 (n = 49) | BIS initiation at week 12 (n = 51) | p value |
---|---|---|---|
Nausea/vomiting | 1 | 1 | 0.095 |
Constipation | – | 1 | |
Diarrhea | 1 | – | |
Myalgia | 2 | – | |
Flu-like symptoms | 1 | – | |
Muscle cramp | – | 1 | |
Hearing impairment | 1 | – | |
Deep vein thrombosis | 1 | – | |
Ischemic stroke | 1 | – | |
Total number of adverse events | 8 (16.3%) | 3 (5.9%) |
Data presented as number or number (%); p value <0.05 indicates statistical significance
BIS bisphosphonate